Search
Tenax Therapeutics Inc
TENXAdd to Watchlist
12.000USD
+0.130+1.10%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
291.31MMarket Cap
LossP/E TTM
Tenax Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Tenax Therapeutics Inc is 7.41, ranking 234 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -8.55, which is -145.65% below the recent high of 3.90 and -187.76% above the recent low of -24.59.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
